As people age, the immune system ages with them, becoming more sluggish and ineffective — a change that could contribute…
Articles by Andrea Lobo
Ncardia has launched a human-derived microglia cell model, called Ncyte Microglia, that the company says may help advance research…
The European Medicines Agency (EMA), which evaluates the safety and efficacy of new drugs in the European Union, has waived…
Parkinson’s disease research and care should address disparities by sex and gender in patients’ symptoms, treatment responses, and disease…
A nanoparticle-based wireless deep brain stimulation (DBS) system restored the activity of degenerating neurons and increased dopamine release in…
Hearing loss may be a risk factor for developing Parkinson’s disease, or may be an early warning sign of…
The Michael J. Fox Foundation (MJFF) has launched this year’s “Parkinson’s IQ + You,” a series of in-person…
A Phase 2 clinical trial of AB-1005, AskBio’s gene therapy for Parkinson’s disease, has randomly assigned its first…
Medtronic’s BrainSense adaptive deep brain stimulation (aDBS) system and electrode identifier have received CE Mark approval in the…
A research project that’s designed to help improve communication for people with Parkinson’s disease by focusing on listener training has…